Showing results (1-10 of 170) with videos related to
Sort By:
Pageof 17
Current Drug Safety|October 18, 2014
Safety of therapeutics used in management of patent ductus arteriosus in preterm infantsMehmet Yekta Oncel, Omer ErdeveWorld Journal of Clinical Pediatrics|February 11, 2016
Oral medications regarding their safety and efficacy in the management of patent ductus arteriosusMehmet Yekta Oncel, Omer ErdeveJournal of Tropical Pediatrics|September 11, 2004
The probiotic effect of Saccharomyces boulardii in a pediatric age groupOmer Erdeve, Ulku Tiras, Yildiz DallarCurrent Clinical Pharmacology|July 17, 2012
Pharmacological Management of PDA: oral versus intravenous medicationsGamze Demirel, Omer Erdeve, Ugur DilmenCongenital Anomalies|April 13, 2025
A cohort study on structural analysis of congenital anomalies in an intensive care unit in AzerbaijanNarmin Akif Azizova, Ismayil Gafarov, Omer ErdeveCroatian Medical Journal|April 17, 2007
Efficacy and safety of nebulized recombinant human DNase as rescue treatment for persistent atelectasis in newborns: case-seriesOmer Erdeve, Nurdan Uras, Begum Atasay, et al.Journal of Clinical Pharmacology|May 22, 2010
Effect of sodium alginate on acid gastroesophageal reflux disease in preterm infants: a pilot studyBegum Atasay, Omer Erdeve, Saadet Arsan, et al.Pediatrics International : Official Journal of the Japan Pediatric Society|January 13, 2016
Early predictive echocardiographic features of hemodynamically significant patent ductus arteriosus in preterm VLBW infantsTugcin Bora Polat, Istemi Han Celik, Omer ErdeveFrontiers in Pediatrics|December 17, 2020
Echocardiographic Diagnosis and Hemodynamic Evaluation of Patent Ductus Arteriosus in Extremely Low Gestational Age Newborn (ELGAN) InfantsYogen Singh, Alain Fraisse, Omer Erdeve, et al.Children (Basel, Switzerland)|July 29, 2023
Indirect Neonatal Hyperbilirubinemia and the Role of Fenofibrate as an Adjuvant to PhototherapySalam K Shabo, Khalaf H Gargary, Omer ErdevePageof 17